Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline
08:30am, Monday, 09'th Dec 2024
Resources realigned to focus primarily on in vivo macrophage engineering platform for fibrosis, oncology and autoimmune disease therapies Development of CT-0525 to be discontinued; workforce reduced
Strong demand for mRNA-based vaccines and therapies continues to fuel market growth in diverse therapeutic areas, including oncology, infectious diseases, and rare genetic disorders. Strong demand for
Moderna, Inc. (MRNA) Piper Sandler 36th Annual Healthcare Conference (Transcript)
02:39pm, Thursday, 05'th Dec 2024
Moderna, Inc. (NASDAQ:MRNA ) Piper Sandler 36th Annual Healthcare Conference December 5, 2024 10:30 AM ET Company Participants Stephane Bancel - Chief Executive Officer Conference Call Participants Te
Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?
06:45am, Thursday, 05'th Dec 2024
The S&P 500 has hit record levels this year and many stocks have generated fantastic returns for investors. But there's been no shortage of struggling investments, either.
Moderna, Inc. (MRNA) 7th Annual Evercore ISI HealthCONx Conference - (Transcript)
08:48pm, Wednesday, 04'th Dec 2024
Moderna, Inc. (NASDAQ:MRNA ) 7th Annual Evercore ISI HealthCONx Conference Call December 4, 2024 1:20 PM ET Company Participants Lavina Talukdar - Senior Vice President and Head of Investor Relations
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
07:30am, Tuesday, 26'th Nov 2024
The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although it's not a part of the U.S. stock market's big three indexes ( S&P 500 , Nasdaq Composite, a
Moderna: Optimistic Outlook Despite The Recent Sell-Off
03:51am, Tuesday, 26'th Nov 2024
Moderna's stock is undervalued, so I maintain a positive outlook with a $97 price target for next year. 3Q24 results show good COVID-19 revenue, cost efficiency, and a significant cash balance, but RS
Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation
06:44pm, Monday, 25'th Nov 2024
Mizuho's Jared Holz joins 'Fast Money' to talk what's next for biopharma space after president-elect Trump names his pick for FDA head.
Moderna to Present at Upcoming Conferences in December 2024
07:00am, Monday, 25'th Nov 2024
CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: 7th Annual Evercore ISI HealthCONx Confe
Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference
02:01pm, Friday, 22'nd Nov 2024
Moderna (MRNA) shares surged further Friday, a day after a senior executive made bullish comments at a healthcare conference about the vaccine maker's pipeline and cash position.
Moderna, Inc. (MRNA) Presents at Jefferies London Healthcare Conference (Transcript)
11:33am, Thursday, 21'st Nov 2024
Moderna, Inc. (NASDAQ:MRNA ) Jefferies London Healthcare Conference November 21, 2024 9:00 AM ET Company Participants Lavina Talukdar - IR Conference Call Participants Michael Yee - Jefferies Michael
BioNTech and Moderna at vanguard of new treatment wave - but which is best?
05:14am, Tuesday, 19'th Nov 2024
The mRNA (messenger RNA) technology that powered the rapid development of COVID-19 vaccines is now driving a broader revolution in medicine. According to Berenberg, this innovative approach has the po
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
01:24pm, Monday, 18'th Nov 2024
Last week, some large European and U.S. vaccine maker stocks fell in reaction to Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services.
Cramer's Mad Dash: Moderna gets upgrade from HSBC
10:51am, Monday, 18'th Nov 2024
CNBC's Jim Cramer reports on the latest news regarding Moderna.
As Drug Maker Stocks Fall, Pressure Builds On PhRMA To Derail RFK, Jr.
10:03pm, Friday, 15'th Nov 2024
Stocks of major drug makers and biotech companies tumbled in trading late this week after President-elect Donald Trump announced that he wants vaccine skeptic Robert F. Kennedy Jr. to lead the U.S. De
